Human Growth Hormone Market by Application and Geography - Forecast and Analysis 2022-2026

Published: Mar 2022 Pages: 130 SKU: IRTNTR73043

Human Growth Hormone Market Size Analysis

The human growth hormone market size is expected to increase by USD 1.16 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.44%.

This human growth hormone market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

  • Abbott.in - The company develops and distributes over 600 products for healthcare professionals that promote health and well-being such as hormones.
  • Ankebio.com - The company offers Ansomone that is indicated for growth failure due to endogenous growth hormone deficiency and turner disease or kidney failure.
  • Ascendispharma.com - The company offers TransCon hGH that is a once-weekly prodrug of somatropin designed to reduce the treatment burden for patients with growth hormone deficiency.

Human Growth Hormone Market Size 

To learn more about this Report Download the Free Report Sample 

Human Growth Hormone Market Overview

The development of long-acting and needle-free deliveries to improve adherence is notably driving the human growth hormone market growth, although factors such as the high cost of human growth hormone treatment may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the human growth hormone industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Human Growth Hormone Market Driver

The advancement of long-acting and needle-free delivery methods is a significant catalyst propelling growth in the human growth hormone market. In the United States, it is estimated that approximately 3%-5% of children grapple with short stature, defined as having a height below the 3rd percentile. Presently, most treatments for these conditions involve the use of needles for drug administration. However, recent research reveals that more than 60% of children aged 6-17 years harbour a fear of needles.

In response to this challenge, many manufacturers of growth hormone products are now dedicated to developing needle-free delivery mechanisms. These innovative initiatives are poised to make a substantial contribution to the growth of the human growth hormone market during the forecast period.

Key Human Growth Hormone Market Trend

The rising prevalence of growth disorders stands out as a significant trend in the human growth hormone market, bolstering its overall growth. Robust research and development efforts have led to a substantial pipeline of potential treatments in this field. Currently, the human growth hormone pipeline boasts approximately sixteen trials in either Phase II or Phase III stages of clinical development. Among these, several promising molecules target a range of growth disorders, including growth hormone deficiency, pediatric growth hormone deficiency, small for gestational age infants, Prader-Willi syndrome (PWS), acromegaly, and dwarfism.

Leading companies such as Novo Nordisk, Merck, and Pfizer have assembled strong pipelines within their portfolios to address various growth hormone disorders. Collectively, these factors are anticipated to propel the global human growth hormone market forward during the forecast period.

Key Human Growth Hormone Market Challenge

The high cost of human growth hormone treatment is one of the factors hindering the human growth hormone market growth. The estimate for the cost of human growth hormone therapy can only be evaluated once the condition, dosage, and treatment process are being defined for a particular individual. However, a few individuals have very low levels of human growth hormone, which result in spending around USD500 on human growth hormone supplements per month. Whereas for others, the minimal dosage of human growth hormone supplements costs around USD200 per month. Therefore, the high cost of these therapeutics is not affordable for many patients in developing and cost-sensitive regions, which, in turn, hinders human growth hormone market growth.

This human growth hormone market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Regional Analysis of Human Growth Hormone Market

For more insights on the market share of various regions Request for a FREE sample now!

37% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for the human growth hormone market in North America. Market growth in this region will be faster than the growth of the market in ROW.

Increasing demand for human growth hormone due to rising growth hormone deficiency diseases and technological advancement will facilitate the human growth hormone market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for Companies , which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The outbreak of COVID-19 in early 2020 led to a rise in the research on identifying and developing human growth hormones in the region. Moreover, by H2 2021, lockdown restrictions were lifted due to the initiation of vaccination drives in the region. This has led to the resumption of R and D for human growth hormone products apart from COVID-19 vaccines. Such factors are expected to drive the growth of the market during the forecast period.

Human Growth Hormone Market Segmentation by Application 

To gain further insights on the market contribution of various segments Request for a FREE sample

The human growth hormone market share growth by the growth hormone deficiency segment will be significant during the forecast period. In 2021, the growth hormone deficiency segment dominated the global human growth hormone market and is expected to maintain its dominance over the forecast period. According to an article published in NCBI by Adda Grimberg et al. in 2015, the estimated prevalence of 1 in 3500 children. Thus, the increasing incidence of growth hormone deficiency is expected to spur market growth during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the human growth hormone market size and actionable market insights on post COVID-19 impact on each segment.

Who are the Major Human Growth Hormone Market Companies?

The report analyzes the market's competitive landscape and offers information on several market Companies, including:

  • Abbott Laboratories
  • Anhui Anke Biotechnology Group Co. Ltd.
  • Ascendis Pharma AS
  • F. Hoffmann La Roche Ltd.
  • Ferring B.V.
  • Ipsen Pharma
  • Merck and Co. Inc.
  • Novo Nordisk AS
  • Pfizer Inc.

This statistical study of the human growth hormone market encompasses successful business strategies deployed by the key Companies. The human growth hormone market is concentrated and Companies are deploying growth strategies such as price, availability, brand, and variety to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market Companies should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The human growth hormone market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Human Growth Hormone Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the human growth hormone market, which Companies can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help Companies drive costs and enhance customer services during the forecast period.

You may be interested in the regional reports:

US Human Growth Hormone market - The market share will grow at a CAGR of 3.86 % over the period 2014-2019.

Human Growth Hormone Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 5.44%

Market growth 2022-2026

USD 1.16 billion

Market structure

Concentrated

YoY growth (%)

4.29

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 37%

Key consumer countries

US, Canada, Denmark, China, and India

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Abbott Laboratories, Anhui Anke Biotechnology Group Co. Ltd., Ascendis Pharma AS, F. Hoffmann La Roche Ltd., Ferring B.V., Ipsen Pharma, Merck and Co. Inc., Novo Nordisk AS, and Pfizer Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Human Growth Hormone Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive human growth hormone market growth during the next five years
  • Precise estimation of the human growth hormone market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the human growth hormone industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market's competitive landscape and detailed information on Companies
  • Comprehensive details of factors that will challenge the growth of human growth hormone market Companies

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Application

    • 5.1 Market segments
      • Exhibit 24: Chart on Application - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
    • 5.2 Comparison by Application
      • Exhibit 26: Chart on Comparison by Application
      • Exhibit 27: Data Table on Comparison by Application
    • 5.3 Growth hormone deficiency - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Growth hormone deficiency - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Growth hormone deficiency - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Growth hormone deficiency - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Growth hormone deficiency - Year-over-year growth 2021-2026 (%)
    • 5.4 ISS - Market size and forecast 2021-2026
      • Exhibit 32: Chart on ISS - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on ISS - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on ISS - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on ISS - Year-over-year growth 2021-2026 (%)
    • 5.5 Turner syndrome - Market size and forecast 2021-2026
      • Exhibit 36: Chart on Turner syndrome - Market size and forecast 2021-2026 ($ million)
      • Exhibit 37: Data Table on Turner syndrome - Market size and forecast 2021-2026 ($ million)
      • Exhibit 38: Chart on Turner syndrome - Year-over-year growth 2021-2026 (%)
      • Exhibit 39: Data Table on Turner syndrome - Year-over-year growth 2021-2026 (%)
    • 5.6 PWS - Market size and forecast 2021-2026
      • Exhibit 40: Chart on PWS - Market size and forecast 2021-2026 ($ million)
      • Exhibit 41: Data Table on PWS - Market size and forecast 2021-2026 ($ million)
      • Exhibit 42: Chart on PWS - Year-over-year growth 2021-2026 (%)
      • Exhibit 43: Data Table on PWS - Year-over-year growth 2021-2026 (%)
    • 5.7 Others - Market size and forecast 2021-2026
      • Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
      • Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
    • 5.8 Market opportunity by Application
      • Exhibit 48: Market opportunity by Application ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 50: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 51: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 52: Chart on Geographic comparison
      • Exhibit 53: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Denmark - Market size and forecast 2021-2026
      • Exhibit 74: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on Denmark - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
    • 7.9 China - Market size and forecast 2021-2026
      • Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.10 Canada - Market size and forecast 2021-2026
      • Exhibit 82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 84: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 7.11 India - Market size and forecast 2021-2026
      • Exhibit 86: Chart on India - Market size and forecast 2021-2026 ($ million)
      • Exhibit 87: Data Table on India - Market size and forecast 2021-2026 ($ million)
      • Exhibit 88: Chart on India - Year-over-year growth 2021-2026 (%)
      • Exhibit 89: Data Table on India - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 90: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 91: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 93: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 94: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 95: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 96: Matrix on vendor position and classification
            • 10.3 Abbott Laboratories
              • Exhibit 97: Abbott Laboratories - Overview
              • Exhibit 98: Abbott Laboratories - Business segments
              • Exhibit 99: Abbott Laboratories - Key offerings
              • Exhibit 100: Abbott Laboratories - Segment focus
            • 10.4 Anhui Anke Biotechnology Group Co. Ltd.
              • Exhibit 101: Anhui Anke Biotechnology Group Co. Ltd. - Overview
              • Exhibit 102: Anhui Anke Biotechnology Group Co. Ltd. - Product / Service
              • Exhibit 103: Anhui Anke Biotechnology Group Co. Ltd. - Key offerings
            • 10.5 Ascendis Pharma AS
              • Exhibit 104: Ascendis Pharma AS - Overview
              • Exhibit 105: Ascendis Pharma AS - Product / Service
              • Exhibit 106: Ascendis Pharma AS - Key offerings
            • 10.6 F. Hoffmann La Roche Ltd.
              • Exhibit 107: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 108: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 109: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 110: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 111: F. Hoffmann La Roche Ltd. - Segment focus
            • 10.7 Ferring B.V.
              • Exhibit 112: Ferring B.V. - Overview
              • Exhibit 113: Ferring B.V. - Product / Service
              • Exhibit 114: Ferring B.V. - Key offerings
            • 10.8 Ipsen Pharma
              • Exhibit 115: Ipsen Pharma - Overview
              • Exhibit 116: Ipsen Pharma - Business segments
              • Exhibit 117: Ipsen Pharma - Key offerings
              • Exhibit 118: Ipsen Pharma - Segment focus
            • 10.9 Merck and Co. Inc.
              • Exhibit 119: Merck and Co. Inc. - Overview
              • Exhibit 120: Merck and Co. Inc. - Business segments
              • Exhibit 121: Merck and Co. Inc. - Key news
              • Exhibit 122: Merck and Co. Inc. - Key offerings
              • Exhibit 123: Merck and Co. Inc. - Segment focus
            • 10.10 Novo Nordisk AS
              • Exhibit 124: Novo Nordisk AS - Overview
              • Exhibit 125: Novo Nordisk AS - Business segments
              • Exhibit 126: Novo Nordisk AS - Key offerings
              • Exhibit 127: Novo Nordisk AS - Segment focus
            • 10.11 Pfizer Inc.
              • Exhibit 128: Pfizer Inc. - Overview
              • Exhibit 129: Pfizer Inc. - Product / Service
              • Exhibit 130: Pfizer Inc. - Key news
              • Exhibit 131: Pfizer Inc. - Key offerings

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 132: Inclusions checklist
                • Exhibit 133: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 134: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 135: Research methodology
                • Exhibit 136: Validation techniques employed for market sizing
                • Exhibit 137: Information sources
              • 11.5 List of abbreviations
                • Exhibit 138: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              human growth hormone market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis